Hypertension Clinical Trial
Official title:
A Randomized, Double-Blind, Multicenter, Parallel Study Evaluating the Efficacy and Safety of a Combination of Ramipril Plus Hydrochlorothiazide Versus the Component Monotherapies in Subjects With Essential Hypertension
Verified date | October 2012 |
Source | Pfizer |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Food and Drug Administration |
Study type | Interventional |
The purpose of this study is to determine if there is greater blood pressure reduction using ramipril or hydrochlorothiazide alone or ramipril and hydrochlorothiazide together.
Status | Completed |
Enrollment | 0 |
Est. completion date | March 2007 |
Est. primary completion date | March 2007 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Previously diagnosed, or newly diagnosed essential hypertension. Blood pressure must be within a minimum and maximum range prior to drug treatment. Exclusion Criteria: - Inability to discontinue all prior antihypertensive medications - Heart failure - History of stroke, myocardial infarction, or chest pain within 3 years, or an abnormal heart rhythm - Liver or kidney disease - Certain drugs used to treat other conditions like an enlarged prostate gland, or arthritis - Allergy or reactions to certain medications used to treat high blood pressure Other protocol-defined inclusion and exclusion criteria apply. |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Executive Health and Research Associates, Inc. | Atlanta | Georgia |
United States | MetaClin Research, Inc. | Austin | Texas |
United States | Impact Clinical Trials | Beverly Hills | California |
United States | Lovelace Scientific Resources, Inc. | Beverly Hills | California |
United States | Cahaba Research Inc. | Birmingham | Alabama |
United States | Twin Cities Clinical Research | Brooklyn Center | Minnesota |
United States | Associated Pharmaceutical Research Center, Inc. | Buena Park | California |
United States | Punzi Medical Center | Carrollton | Texas |
United States | Medical Research South | Charleston | South Carolina |
United States | Cedar Crosse Research Center | Chicago | Illinois |
United States | James R. Herron, MD, Ltd. | Chicago | Illinois |
United States | Sterling Research Group, Inc. | Cincinnati | Ohio |
United States | Clinical Research of West Florida, Inc. | Clearwater | Florida |
United States | SC Clinical Research Center, LLC | Columbia | South Carolina |
United States | Clinical Research of South Florida | Coral Gables | Florida |
United States | Research Across America | Dallas | Texas |
United States | University Clinical Research Deland, Inc. | Deland | Florida |
United States | University of Connecticut Health Center | Farmington | Connecticut |
United States | Cumberland Research Assocites, LLC | Fayetteville | North Carolina |
United States | Pulmonary Associates | Glendale | Arizona |
United States | Marin Endocrine Care and Research | Greenbrae | California |
United States | Radiant Research - Greer | Greer | South Carolina |
United States | Clinical Investigation Specialists, Inc. | Gurnee | Illinois |
United States | Unifour Medical Research Associates | Hickory | North Carolina |
United States | South Florida Clinical Research Center | Hollywood | Florida |
United States | Clinical Research Associates | Huntsville | Alabama |
United States | Midwest Institute for Clinical Research | Indianapolis | Indiana |
United States | Radiant Research - Tacoma | Lakewood | Washington |
United States | Innovative Research of West Florida | Largo | Florida |
United States | Advanced Biomedical Research of America | Las Vegas | Nevada |
United States | Michigan Institute of Medicine | Livonia | Michigan |
United States | Memorial Research Medical Clinic | Long Beach | California |
United States | National Research Institute | Los Angeles | California |
United States | The Intermed Group; Samaritan Medical Tower | Los Angeles | California |
United States | Smith Clinical Research | Marion | Ohio |
United States | Medford Medical Clinic Research Dept. | Medford | Oregon |
United States | International Research Associates, LLC | Miami | Florida |
United States | Lifespan Research Foundation | Miami | Florida |
United States | Radiant Research - Mogadore | Mogadore | Ohio |
United States | Sun Coast Clinical Research | New Port Richey | Florida |
United States | Clinical Research Associates of Tidewater | Norfolk | Virginia |
United States | Lion Research | Norman | Oklahoma |
United States | Renstar Medical Research | Ocala | Florida |
United States | Suncoast Clinical Research, Inc. | Palm Harbor | Florida |
United States | University Clinical Research, Inc. | Pembroke Pines | Florida |
United States | Philadelphia Health Associates | Philadelphia | Pennsylvania |
United States | Triangle Medical Research Associates | Raleigh | North Carolina |
United States | Clinical Trials Research | Roseville | California |
United States | Radiant Research - San Antonio | San Antonio | Texas |
United States | WellMed Medical Management | San Antonio | Texas |
United States | Lovelace Scientific Resources | Sarasota | Florida |
United States | The Lipid Center | Statesville | North Carolina |
United States | Bayview Research Group | Studio City | California |
United States | Viking Clinical Research | Temecula | California |
United States | Medical Research Associates | Traverse City | Michigan |
United States | The Chase Wellness Center, Inc | Virginia Beach | Virginia |
United States | Partners in Primary Care | Voorhees | New Jersey |
United States | Metabolic Research Institute, Inc. | West Palm Beach | Florida |
United States | Lyndhurst Gynecologic Associates, PA | Winston-Salem | North Carolina |
United States | Piedmont Medical Research Associates | Winston-Salem | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Pfizer |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Compare the effects on sitting diastolic blood pressure of two antihypertensive drugs in combination against each antihypertensive alone after an eight week treatment period. | |||
Secondary | Compare the effect on sitting diastolic blood pressure of two antihypertensive drugs in combination taken once daily against one antihypertensive drug taken twice daily. | |||
Secondary | Compare the effect on sitting diastolic blood pressure of a dose of an antihypertensive drug taken once daily against half of the same dose taken twice daily. | |||
Secondary | Compare the effect on the sitting and standing blood pressure among all treatment groups. | |||
Secondary | Compare the safety of each medication regimen stated above. | |||
Secondary | Compare the effect on mean 24-hour diastolic blood pressure (ABPM) of the medication regimens stated above. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |